Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00510237 · ClinicalTrials.gov registry record · NA

Intervention for Newly Diagnosed Youth With HIV

A NA study of HIV, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
50
Enrollment target
4
Study locations

NCT00510237 is a NA study of HIV that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 50 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (89% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00510237, a NA study of HIV, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
4
Study locations

Study Summary

This study will pilot test an HIV intervention for newly diagnosed youth (diagnosed for less than 15 months) to assess its acceptability and feasibility preliminary to and leading up to a full-scale, randomized trial. The general focus of the intervention is to aid in the psychosocial adjustment of adolescents who have recently been diagnosed with HIV.

Conditions Studied

Interventions

  • BEHAVIORAL "Adolescents Coping, Connecting, Empowering, and Protecting Together" (Project ACCEPT)

Study Locations (4)

Florida

  • University of Miami School of Medicine - Miami

Illinois

  • John Stroger Jr. Hospital of Cook County - Chicago

New York

  • Montefiore Medical Center - The Bronx

Tennessee

  • St. Jude Children's Research Hospital - Memphis

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2007-02
Est. Completion 2009-01
Phase NA

What the Registry Record Tells You About NCT00510237

The ClinicalTrials.gov registry entry for NCT00510237 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (89% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 1 intervention - of which "Adolescents Coping, Connecting, Empowering, and Protecting Together" (Project ACCEPT) is the first listed.

NCT00510237 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Florida, Illinois, New York.

Frequently Asked Questions

What is clinical trial NCT00510237 about?

NCT00510237 is a clinical study titled "Intervention for Newly Diagnosed Youth With HIV". This study will pilot test an HIV intervention for newly diagnosed youth (diagnosed for less than 15 months) to assess its acceptability and feasibility preliminary to and leading up to a full-scale, randomized trial. The general focus of the intervention is to aid in the psychosocial adjustment of ...

What is the current status of trial NCT00510237?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2007-02. Estimated completion is 2009-01.

What conditions does trial NCT00510237 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT00510237?

The interventions under investigation include: "Adolescents Coping, Connecting, Empowering, and Protecting Together" (Project ACCEPT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00510237?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00510237 being conducted?

This trial has 4 study locations across Florida, Illinois, New York, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.